Savvy investors know that change creates opportunities. And a major change is underway at the nation's central bank. Kevin ...

Pfizer could attract investors if Warsh's "regime change" at the Fed leads to market turbulence.

In early May 2026, Pfizer reported first-quarter revenue of US$14.45 billion and net income of US$2.69 billion, with earnings ...

Could a patent infringement case filed against Pfizer just before the holiday help Elan CEO Kelly Martin in his negotiations with Wyeth over revenues from bapineuzamab, his Alzheimer's drug? The ...

The last time I spoke about Pfizer (PFE) it was with respect to a Seeking Alpha article entitled "Pfizer: Downgrade To 'Hold' On Lower 2026 Revenue Guidance And Potential Growth Tracks". With respect ...

Pfizer shares are trading in the mid-$20s as investors grapple with a critical question: is this battered pharmaceutical giant destined to remain stuck in neutral, or does its aggressive push into ...

Pharmaceutical giant Pfizer (NYSE: PFE) was a big winner during the COVID-19 pandemic. Its vaccine and antiviral pill generated billions of dollars in sales. However, that revenue source has largely ...